Andreano KJ, Wardell SE, Baker JG, Desautels TK, et al. G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer. Breast Cancer Res Treat 2020 Mar 4. pii: 10.1007/s10549-020-05575.
PMID: 32130619